AZARGA Transition Study in Taiwan for Patients With Uncontrolled Intraocular Pressure
Completed · Phase 4
Conditions studied: Glaucoma
In brief
The purpose of this study was to assess the safety and efficacy of switching to Azarga from prior pharmacotherapy in patients with open-angle glaucoma.
Key facts
- Study ID
- NCT01484951
- Run by
- Alcon Research
- People needed
- 74
- Starts
- 2011-05-01
- Expected to finish
- 2012-03-01
- Last updated by the study team
- 2013-05-01
Who can join
Age: 20 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Clinical diagnosis of ocular hypertension, primary open-angle or pigment dispersion glaucoma in both eyes.
- Must be on a stable regimen of intra-ocular pressure (IOP) lowering medication within one week of screening/baseline visit.
- Must have an IOP of between 19 and 35 mmHg (both inclusive) in at least one eye, which would be the study eye, at screening.
- Must be willing to discontinue the use of all other ocular hypotensive medications prior to receiving the study medication for the entire course of the study.
- Must have best corrected visual acuity of 6/60 (20/200 Snellen, 1.0 LogMAR) or better in each eye.
- Other protocol-defined inclusion criteria may apply.
You may not qualify if…
- Known medical history of allergy, hypersensitivity, or poor tolerance to any component of the medication to be used in the study deemed clinically significant in the opinion of the principal investigator.
- Any abnormality preventing reliable applanation tonometry in either eye.
- Risk of visual field or visual acuity worsening as a consequence of participating in this study, in the investigator's best judgment.
- Pregnant or lactating.
- Participation in any other investigational study within 30 days of screening visit.
- Other protocol-defined exclusion criteria may apply.
Where it is running
- Contact Alcon Call Center for Trial Locations — Fort Worth, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.